Bluejay Diagnostics, Inc. Related Party Transaction, Expenses from Transactions with Related Party
Bluejay Diagnostics, Inc. (BJDX) reported Related Party Transaction, Expenses from Transactions with Related Party of $48.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2023-03-20
- Bluejay Diagnostics, Inc. related party transaction, expenses from transactions with related party for fiscal 2021 was $48.00K, a 12.88% decline from fiscal 2020.
- Bluejay Diagnostics, Inc. related party transaction, expenses from transactions with related party for fiscal 2020 was $55.10K.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|
| 2021-12-31 | $48.00K 10-K · filed 2023-03-20 |
| 2020-12-31 | $55.10K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |